Profound Medical Corp. cash flow to debt ratio of -602.38% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Profound Medical Corp.'s free cash flow has decreased 66.52% from $-23.45M last year to $-39.05M, signaling decreasing performance

Profound Medical Corp.'s debt to equity ratio is 0.15, which means that the company's assets are healthy financed, signaling financial stability.

Profound Medical Corp.'s debt has increased relative to shareholder equity from 0.08 last year to 0.15 today, signaling weakened financials

Profound Medical Corp. has a net cash position, so leverage is healthy.

Profound Medical Corp. earns at least as much interest as it pays. Interest obligations are fully covered.

Profound Medical Corp.'s profit margin has increased (-34.37%) in the last year from -260.45% to -170.92%, signaling increasing performance

Profound Medical Corp.'s short-term assets of $104.21M exceed its short-term liabilities of $8.32M

Profound Medical Corp.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Profound Medical Corp.'s return on equity of -62.45%, is lower than 15.00%, indicating bad performance

Profound Medical Corp.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Profound Medical Corp. had positive net income in only 0 out of 5 years, indicating unstable earnings

Profound Medical Corp. has negative free cash flow, indicating the company is burning cash rather than generating it

Profound Medical Corp. has negative free cash flow, indicating cash burn

Profound Medical Corp.'s yearly earnings has decreased 63.57% since last year from $-26.48M to $-43.32M, signaling decreasing performance

Profound Medical Corp.'s yearly revenue has increased 50.73% since last year from $10.68M to $16.10M, signaling increasing performance

ROIC -60.49% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Profound Medical Corp.'s 3-year revenue CAGR of 34.84% is positive, indicating growing revenue over the past 3 years

Profound Medical Corp. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Profound Medical Corp. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Profound Medical Corp. has insufficient data to evaluate this check.

Profound Medical Corp. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Profound Medical Corp. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Profound Medical Corp. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Profound Medical Corp. is overvalued relative to its fair value price of -41.68 based on Earnings Fair Value model

Profound Medical Corp. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Profound Medical Corp. has a price-to-book ratio of 5.37x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Profound Medical Corp. has a price-to-sales ratio of 14.07x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue